Design
Review
No takes yet. Share an insight, caveat, or question.
Positions vascular aging as modifiable driver of health span; leaves open which precision biomarkers and senolytics will prove effective in trials.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: